158,500 Shares in M3-Brigade Acquisition V Corp. $MBAV Purchased by FNY Investment Advisers LLC

FNY Investment Advisers LLC bought a new stake in M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 158,500 shares of the company’s stock, valued at approximately $1,672,000. FNY Investment Advisers LLC owned about 0.44% of M3-Brigade Acquisition V as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Whitebox Advisors LLC lifted its holdings in shares of M3-Brigade Acquisition V by 18.2% during the third quarter. Whitebox Advisors LLC now owns 130,000 shares of the company’s stock worth $1,372,000 after buying an additional 20,000 shares during the last quarter. Prelude Capital Management LLC bought a new stake in shares of M3-Brigade Acquisition V in the third quarter valued at approximately $281,000. Sandia Investment Management LP acquired a new stake in shares of M3-Brigade Acquisition V in the second quarter worth $334,000. Clear Street LLC grew its stake in shares of M3-Brigade Acquisition V by 2,280.8% in the second quarter. Clear Street LLC now owns 32,069 shares of the company’s stock worth $362,000 after acquiring an additional 30,722 shares during the last quarter. Finally, Millennium Management LLC increased its position in M3-Brigade Acquisition V by 49.9% during the third quarter. Millennium Management LLC now owns 150,000 shares of the company’s stock worth $1,582,000 after acquiring an additional 49,946 shares during the period.

M3-Brigade Acquisition V Trading Up 0.4%

Shares of MBAV stock opened at $10.70 on Thursday. M3-Brigade Acquisition V Corp. has a 12 month low of $10.19 and a 12 month high of $13.73. The stock has a 50 day moving average of $10.68 and a two-hundred day moving average of $10.63.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research note on Monday, December 22nd. Wall Street Zen upgraded shares of M3-Brigade Acquisition V to a “sell” rating in a report on Saturday, March 14th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

About M3-Brigade Acquisition V

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.